Related Experiment Video

Updated: May 2, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.4K

Prevalence of thrombocytopenia in Egyptian patients with chronic hepatitis C virus

Sayed Farouk Mohamed

    Journal of the Egyptian Society of Parasitology
    |March 20, 2014
    PubMed

    Thrombocytopenia is defined as a platelet count less than 150.000/mm3. It is a common finding in subjects with chronic hepatitis as HCV antibody-positive individuals are 2.6 times more likely to have a low platelet count than those who are HCV-antibody negative. However, controversy still exists concerning the mechanism of HCV-associated thrombocytopenia This work studied the thrombocytopenia prevalence in Egyptian patients with chronic HCV. Data of 100 patients with chronic hepatitis C presented to Tropical Medicine department, Al-Azhar University, included full history, clinical assessment, laboratory investigations (complete blood count, liver biochemical profile, kidney function tests and PCR), abdominal ultrasound and liver biopsy. The prevalence of thrombocytopenia among patients was 24/100 (24%), mild thrombocytopenia was the commonest grade (17%) then moderate one (6%) and lastly severe thrombocytopenia (1%). Thrombocytopenia significantly occurred more in older ages with high AST and ALT levels. The prevalence of thrombocytopenia significantly increased with abnormality liver Echopattern and with the progress of fibrosis and activity in liver biopsy.

    More Related Videos

    Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection11:14

    Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

    Published on: November 7, 2018

    21.5K
    Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection04:11

    Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

    Published on: December 15, 2023

    5.5K

    Related Concept Videos

    Hepatitis01:25

    Hepatitis

    Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
    86
    Viral Hepatitis I: Introduction01:28

    Viral Hepatitis I: Introduction

    Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
    25
    Chronic Kidney Disease II: Clinical Manifestations01:24

    Chronic Kidney Disease II: Clinical Manifestations

    Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
    1.1K
    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

    Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
    382
    Portal Hypertension01:22

    Portal Hypertension

    Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
    50
    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

    In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
    271